β-catenin mutations and expression, 249serine p53 tumor suppressor gene mutation, and hepatitis B virus infection in southern African blacks with hepatocellular carcinoma

Journal of Surgical Oncology

Volumn 91, Issue 4, 2005, Pages 258-263

  Elmileik, Hashim ^a   Paterson, Alan C ^b   Kew, Michael C ^a,c  

^a SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c UNIVERSITY OF THE WITWATERSRAND MEDICAL SCHOOL   (South Africa)

Author keywords

Aflatoxin B1; Hepatitis B virus surface antigenemia; Histochemical staining; Malignant and benign hepatocytes

Indexed keywords

AFLATOXIN B1; BETA CATENIN; COMPLEMENTARY DNA; GENOMIC DNA; PROTEIN P53; RNA;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE MUTATION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL; LIVER CELL CARCINOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE; VIRUS HEPATITIS;

AFRICA, SOUTHERN; AFRICAN CONTINENTAL ANCESTRY GROUP; BETA CATENIN; CARCINOMA, HEPATOCELLULAR; CYTOSKELETAL PROTEINS; DNA MUTATIONAL ANALYSIS; GENES, P53; HEPATITIS B; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANS-ACTIVATORS;

EID: 24644524525     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/jso.20304     Document Type: Article

References (40)

1. Bressac B, Kew MC, Wands JR, et al.: Selective G to T mutation of p53 gene in hepatocellular carcinoma from southern Africa. Nature 1991;350:429-431.
2. Kirk GD, Camos-Randon AM, Mendy M, et al.: Ser-249 p53 mutation in the plasma of patients with hepatocellular carcinoma from The Gambia. J Natl Cancer Inst 2000;92:148-153.
3. 1 and hepatitis B virus infection in hepatocarcinogenesis. Liv Int 2003; 23:1-5.
4. Polakis P: Wnt signaling and cancer. Genes Dev 2000;14:1837-1851.
5. de la Coste A, Romagnolo B, Billuart P, et al.: Somatic mutations of the β-catenin gene are frequent in mouse and human hepatocellular carcinoma. Proc Natl Acd Sci USA 1998;95:8847-8851.
6. Miyoshi Y, Iwao K, Nasagawa Y, et al.: Activation of the β-catenin gene in primary hepatocellular carcinomas. Cancer Res 1998;58:2524-2527.
7. Terris B, Pineau P, Bregaud L, et al.: Close correlation between β-catenin gene alterations and nuclear accumulation of the protein in human hepatocellular carcinomas. Oncogene 1999;18:6583-6588.
8. Cui J, Zhou X, Liu Y, et al.: Wnt signaling in hepatocellular carcinoma: Analysis of mutation and expression of β-catenin, T-cell factor-4 and glycogen synthase kinase 3-β genes. J Gastroenterol Hepatol 2003;218:280-287.
9. Damalas A, Ben-Ze'ev I, Simcha I, et al. Excess β-catenin promotes accumulation of transcriptionally active p53. EMBO J 1999;18:3054-3063.
10. Sadot E, Geiger B, Oren M, et al.: Down-regulation of β-catenin by activated p53. Mol Cell Biol 2001;21:6768-6781.
11. Hsu HC, Jeng YM, Mao TL, et al.: β-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis. Am J Pathol 2000;157:763-770.
12. Cha MY, Kim CM, Park YM, et al.: Hepatitis B virus X gene is essential for the activation of Wnt/Beta-catenin signaling in hepatoma cells. Hepatology 2004;39:1883-1893.
13. Gumbinner BM: Signal transduction of β-catenin. Curr Opin Cell Biol 1995;7:634-640.
14. Behrens J, Von Kries JP, Kuhl M, et al.: Functional interaction of β-catenin with the transcription factor LEF-1. Nature 1996;382: 638-642.
15. Peifer M: β-catenin as oncogene. The smoking gun. Science 1997;275:1752-1753.
16. Porfiri E, Rubinfield B, Albert I, et al.: Induction of β-catenin-LEF-1 complex by Wnt-1 and transforming mutants of beta-catenin. Oncogene 1997;15:2833-2839.
17. Munemutsu S, Albert I, Souza B, et al.: Regulation of intracellular β-catenin levels by the adenomatous polyposis coli tumor suppressor gene. Proc Natl Acd Sci USA 1995;92:3046-3050.
18. Papfoff J, Rubinfield B, Schryver B, et al.: Wnt-1 regulates free pools of catenins and stabilizes APC-catenin complexes. Mol Cell Biol 1996;16:2128-2134.
19. Hsu HC, Galceran J, Grosschedl R: Modulation of transcriptional regulation by LEF-1 in response to Wnt-1 signalling and association with β-catenin. Mol Cell Biol 1998; 18:4807-4818.
20. Kraus C, Liehr T, Hulsken J, et al.: Localisation of the human catenin gene (CTNNB1) to 3p21: A region implicated in tumor development. Genomics 1994;23:272-274.
21. He TC, Sparks AB, Rago C, et al.: Identification of c-myc as a target of the APC pathway. Science 1998;281:1509-1512.
22. Shtutman M, Zhurinsky J, Simcha I, et al.: The cyclin D1 gene is a target of the β-catanin/Kef-1 pathway. Proc Natl Acd Sci USA 1999;96:5522-5527.
23. Wei Y, Van Nhieu JT, Prigent S, et al.: Altered expression of E-cadherin in hepatocellular carcinoma: Correlations with genetic alterations, β-catenin expression, and clinical features. Hepatology 2002;36:692-701.
24. Herath NI, Walsh MD, Kew MC, et al.: Cadherin/catenin complex appears to be intact in hepatocellular carcinomas from Australia and South Africa. J Gastroenterol Hepatol 2004;19:676-682.
25. Wong CM, Fan ST, Ng IO: β-catenin mutation and overexpression in hepatocellular carcinoma: Clinicopathologic and prognostic significance. Cancer 2001;92:136-145.
26. Ueta T, Ikeguchi M, Hirooka Y, et al.: β-catenin and cyclin D1 expression in human hepatocellular carcinoma. Oncol Rep 2002; 9:1197-1203.
27. Suzuki T, Yano H, Nakashima Y, et al.: β-catenin expression in hepatocellular carcinoma: A possible participation of beta-catenin in the dedifferentiation process. J Gastroenterol Hepatol 2002;17: 994-1000.
28. Inagawa S, Itabashi M, Adachi S, et al.: Expression and prognostic roles of β-catenin in hepatocellular carcinoma: Correlation with tumor progression and postoperative survival. Clin Cancer Res 2002;8:450-456.
29. Cagatay T, Ozturk M: p53 mutation as source of aberrant β-catinin accumulation in cancer cells. Oncogene 2002;21:7971-7980.
30. Prange W, Breuhahn K, Fischer F, et al.: β-catenin accumulation in the progression of human hepatocarcinogenesis correlates with loss of E-cadherin and accumulation of p53, but not with the expression of conventional Wnt-1 target genes. J Pathol 2003;201: 250-259.
31. Edamoto Y, Hara A, Biernat W, et al.: Alterations of RB1, p53 and Wnt pathways in hepatocellular carcinoma associated with hepatitis C, hepatitis B, and alcoholic cirrhosis. Int J Cancer 2003;106:334-341.
32. Devereux TR, Ann CH, Foley JF, et al.: Mutation of β-catenin is an early event in chemically-induced mouse hepatocellular carcinogenesis. Oncogene 1999;18:4726-4733.
33. 1. J Surg Oncol 2004;86:157-163.
34. Sadot E, Geiger B, Oren M, et al.: Down regulation of β-catenin by activated p53. Mol Cell Biol 2001;21:6768-6781.
35. Damalas A, Ben-Ze'ev A, Simcha M, et al.: Excess β-catenin promotes accumulation of transcriptionally active p53. EMBO J 1999;18:3054-3063.
36. Damalas A, Kahan S, Shtutman M, et al.: Deregulated β-catenin induces a p53- and ARF-dependent growth arrest and co-operates with Ras transformation. EMBO J 2001;17:4912-4922.
37. Liu J, Stevens J, Rote CA, et al.: Siah-1 mediates a novel β-catenin degradation pathway linking p53 to the adenomatous polyposis coli protein. Mol Cell 2001a;7:927-936.
38. Ozturk M, Bressac B, Pusiux A, et al.: A p53 mutational hotspot in primary liver cancer is geographically related to high aflatoxin areas in the world. Lancet 1991;338:1356-1359.
39. Hsu IC, Metcalf RA, Sun T, et al.: Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 1991;350:427-429.
40. 1 and p53 codon 249 mutation in hepatocellular carcinoma from Guangxi, People's Republic of China and a meta-analysis of existing studies. Cancer Epidemiol Biomark Prev 2001;10:617-625.